High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

Journal of the National Cancer Institute

Volumn 92, Issue 15, 2000, Pages 1260-1266

  Borg, Åke ^a   Sandberg, Therese ^a   Nilsson, Kerstin ^a   Johannsson, Oskar ^a   Klinker, Mikael ^a   Måsbäck, Anna ^a   Westerdahl, Johan ^a   Olsson, Håkan ^a   Ingvar, Christian ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIN DEPENDENT KINASE 4; PROTEIN P16; VALINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MALE; MELANOMA; MISSENSE MUTATION; MULTIPLE CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; TUMOR SUPPRESSOR GENE;

EID: 0034596343     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.15.1260     Document Type: Article

References (43)

1. Genetic predisposition to melanoma
2. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
3. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
4. A cell cycle regulator potentially involved in the genesis of many tumor types
5. Deletions of the cyclindependent kinase-4 inhibitor gene in multiple human cancers
6. Malignant melanoma: Modern black plague and genetic black box
7. The p16INK4a/CDKN2A tumor suppressor and its relatives
8. Germline p16 mutations in familial melanoma
9. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
10. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
11. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds
12. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
13. Prevalence of germ-line mutations in p16, pl9ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population
14. Novel germline p16 mutation in familial malignant melanoma in southern Sweden
15. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
16. Germline mutations of the CDKN2A gene in UK melanoma families
17. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
18. CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas
19. CDKN2a/p16ink4a mutations and lack of pI9ARF involvement in familial melanoma kindreds
20. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
21. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
22. Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines
23. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
24. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
25. Typing of human paPillbomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis
26. Temperature-sensitive mutants of p 16CDKN2 associated with familial melanoma
27. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF
28. CDKN2A variants in a population-based sample of Queensland families with melanoma
29. Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: Correlation with protein structure information
30. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma
31. CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein
32. Mutations associated with familial melanoma impair p16INK4 function
33. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
34. Cancer-associated missense and deletion mutations impair p16INK4 CDK inhibitory activity
35. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele
36. CDKN2A mutations in multiple primary melanomas
37. Multiple primary melanomas: Implications from screening and follow-up programs for melanoma
38. Increased risk of pancreatic cancer in melanomaprone kindreds with pl6INK4 mutations
39. Brief report: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene
40. Familial melanoma and pancreatic cancer
41. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group
42. Interaction of breast cancer and melanoma genotypes